Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites

被引:56
作者
Olesen, OV
Linnet, K
机构
[1] Inst. for Basic Res. in Psychiatry, Department of Biological Psychiatry, Aarhus University Hospital, DK-8240 Risskov
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 675卷 / 01期
关键词
citalopram; desmethylcitalopram;
D O I
10.1016/0378-4347(95)00347-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simplified method for the determination of racemic citalopram and its main metabolite desmethylcitalopram in serum using HPLC was developed. The compounds were extracted with heptane-isoamyl alcohol (98:2) and subsequently transferred into phosphate buffer pH 2.5 for direct injection into the HPLC apparatus. The analytes were separated with an acetonitrile-phosphate buffer, pH 2.5-tetraethylamine mobile phase on a C-18 column and measured by UV detection at 240 nm. Within the typical range of serum concentrations (30-200 ng/ml) the inter-day variation was <6% for both compounds. Possible analytical interference from a number of commonly coadministered psychoactive drugs and their metabolites was studied by extracting sera from patients receiving these drugs. Interference was not a problem for the developed method.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 15 条
[1]   COMPARATIVE PHARMACOKINETICS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS - A LOOK BEHIND THE MIRROR [J].
BAUMANN, P ;
ROCHAT, B .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 :15-21
[2]   RELATIONSHIP BETWEEN CLINICAL EFFECTS, SERUM DRUG CONCENTRATION AND SEROTONIN UPTAKE INHIBITION IN DEPRESSED-PATIENTS TREATED WITH CITALOPRAM - A DOUBLE-BLIND COMPARISON OF 3 DOSE LEVELS [J].
BJERKENSTEDT, L ;
FLYCKT, L ;
OVERO, KF ;
LINGJAERDE, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (05) :553-557
[3]   CITALOPRAM - A HIGHLY SELECTIVE 5-HT UPTAKE INHIBITOR IN THE TREATMENT OF DEPRESSED-PATIENTS - AN OPEN CLINICAL-TRIAL WITH STEADY-STATE CONTROL [J].
DUFOUR, H ;
BOUCHACOURT, M ;
THERMOZ, P ;
VIALA, A ;
ROP, PP ;
GOUEZO, F ;
DURAND, A ;
PETERSEN, HEH .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1987, 2 (03) :225-237
[4]  
FRIDERICSON K, 1981, J CHROMATOGR, V224, P526
[6]   THE PHARMACOLOGICAL EFFECT OF CITALOPRAM RESIDES IN THE (S)-(+)-ENANTIOMER [J].
HYTTEL, J ;
BOGESO, KP ;
PERREGAARD, J ;
SANCHEZ, C .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1992, 88 (02) :157-160
[7]   CITALOPRAM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN DEPRESSIVE-ILLNESS [J].
MILNE, RJ ;
GOA, KL .
DRUGS, 1991, 41 (03) :450-477
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CITALOPRAM AND 4 OF ITS METABOLITES IN PLASMA AND URINE SAMPLES FROM PSYCHIATRIC-PATIENTS [J].
OYEHAUG, E ;
OSTENSEN, ET ;
SALVESEN, B .
JOURNAL OF CHROMATOGRAPHY, 1984, 308 (JUN) :199-208
[9]   DETERMINATION OF THE ANTI-DEPRESSANT AGENT CITALOPRAM AND METABOLITES IN PLASMA BY LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
OYEHAUG, E ;
OSTENSEN, ET .
JOURNAL OF CHROMATOGRAPHY, 1982, 227 (01) :129-135
[10]   DETERMINATION OF PLASMA-LEVELS OF CITALOPRAM AND ITS DEMETHYLATED AND DEAMINATED METABOLITES BY GAS-CHROMATOGRAPHY AND GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
REYMOND, P ;
AMEY, M ;
SOUCHE, A ;
LAMBERT, S ;
KONRAT, H ;
EAP, CB ;
BAUMANN, P .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 616 (02) :221-228